TB-500 Pen 5 mg
5mg99,00 € incl. VAT
TB-500 Pen 5 mg: pre-filled pen with TB-500 (synthetic peptide derived from thymosin beta-4) as a ready-to-use solution, 5 mg in a 2 mL cartridge (2.5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
Pre-order
Shipping from 11,93 € · Free EU shipping over 200 €
📋 View the Certificate of Analysis information
Product specifications
| Quantity | 5mg |
|---|---|
| Unit | 1 pre-filled pen |
| Purity data | >99.8% (batch XD-BT5-PO06) |
| Format | Pre-mixed pen (solution in cartridge) |
| Volume | 2 mL solution |
| Concentration | 2.5 mg/mL |
| Storage | 2–8 °C, protected from light |
| Source lot | XD-BT5-PO06, tested by Liquilabs |
Description
Research use only. Sold for laboratory research. Not a medicine, and not for human or veterinary use.
Pre-order
This pen is being prepared for its first production run. Orders placed now are reserved and ship as soon as stock arrives; you will get an email with tracking the day it leaves.
What is TB-500?
TB-500 is the synthetic form of thymosin beta-4, a 43-amino-acid peptide present in almost every human cell and concentrated in platelets and wound fluid. Its main known role is binding actin, the protein cells use to move and change shape, which is why it is studied wherever cells need to migrate to repair tissue.
What the research shows
- Cell migration and wound closure. It speeds the movement of skin and endothelial cells and accelerated wound healing in animal models.
- Blood vessels. It promotes the formation of new vessels.
- Heart. In mice it improved the survival of heart-muscle cells and cardiac function after infarction (Bock-Marquette et al., Nature 2004).
- Eye. Thymosin beta-4 eye drops have reached clinical trials for corneal healing and dry eye.
- Inflammation and scarring. Lower inflammatory signalling and less scar tissue in several animal models.
- Hair. Faster hair growth in rodent studies.
Side effects reported in studies
Thymosin beta-4 was well tolerated in early-phase human trials. Long-term human data for injected TB-500 do not exist. It is on the WADA prohibited list.
Doses reported in published studies
There is no established human dose for injected TB-500. A phase 1 trial of intravenous thymosin beta-4 in healthy volunteers tested 42, 140, 420 and 1,260 mg, first as a single dose and then daily for 14 days, with no dose-limiting toxicity. Animal studies dose by body weight.
This section summarises the doses used in the published literature. It is not a recommendation.
About the pre-mixed pen format
A pre-mixed pen holds the peptide already reconstituted inside a sealed cartridge, so there is no vial to open, no solvent to measure and no transfer step. The solution stays in a closed system from filling to use, and the dial delivers the same volume on every click. Each pen is filled from a lot of lyophilised substance that has already been through independent testing; the lot number is shown on this page.
Supplied as one pre-filled pen, without other accessories.
Pen or vial?
| Pen | Vial | |
|---|---|---|
| Form on arrival | Solution in a cartridge (dual-chamber: powder and solvent, mixed on activation) | Lyophilised powder |
| Reconstitution | Not needed | Done by the user with bacteriostatic water |
| Measuring | Dial, fixed volume per click | Syringe, calculated per draw |
| Handling steps | One | Several |
| Price per mg | Higher | Lower |
| Best for | Convenience and repeatable volumes | Lowest cost and the longest unopened shelf life |
Prefer the lyophilised vial? See TB-500 5mg.
Storage
Keep the pen refrigerated at 2–8 °C, in its box and away from light. Do not freeze. Do not use if the solution is cloudy, discoloured or contains particles. Short temperature excursions during shipping are expected and are covered by insulated packaging.
Quality and Certificate of Analysis
The substance in this pen comes from lot XD-BT5-PO06, tested by Liquilabs, an independent laboratory: >99.8% purity by HPLC, with identity confirmed and endotoxin and heavy metals tested on the same report. The report is published in our lab reports archive, and the lot number can be checked on the laboratory's own site. The certificate describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.
Frequently asked questions
When will my pre-ordered TB-500 Pen 5 mg ship?
As soon as the first production run arrives. You receive tracking by email on the day it leaves.
Does the TB-500 Pen 5 mg need to stay cold?
Yes. Keep it at 2–8 °C. It ships in insulated packaging.
What does the Certificate of Analysis cover?
The lot of lyophilised substance the pen was filled from. The finished solution in the pen has not been analysed separately.
What is in the box?
One pre-filled pen. Needles and other accessories are not included at the moment.
Is it the same substance as the vial?
Yes. It is the same substance in a different format.
Batch test records
The substance in this pen comes from the lot below. The report describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.
- Tested
- September 19, 2026
- Assay
- Purity, Endotoxin, Heavy metals
- Purity
- >99.8%
You Might Also Like
BPC-157 Pen 5 mg: pre-filled pen with BPC-157 (synthetic 15-amino-acid peptide) as a ready-to-use solution, 5 mg in a 2 mL cartridge (2.5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
GHK-Cu Pen 50 mg: pre-filled pen with GHK-Cu (copper tripeptide) as a ready-to-use solution, 50 mg in a 2 mL cartridge (25 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
GLP-3 (Retatrutide) Pen 10 mg: pre-filled pen with retatrutide (triple GIP/GLP-1/glucagon receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
GLP-3 (Retatrutide) Pen 20 mg Dual-Chamber: dual-chamber pen with 20 mg of lyophilised retatrutide (triple GIP/GLP-1/glucagon receptor agonist) and 1 mL of water in separate chambers of one cartridge. Activation mixes them to 20 mg/mL, so the peptide ships and stores as a dry powder. Certificate of Analysis coming soon. For laboratory research use only.
NAD+ Pen 500 mg: pre-filled pen with NAD+ (nicotinamide adenine dinucleotide) as a ready-to-use solution, 500 mg in a 2 mL cartridge (250 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
PT-141 Pen 10 mg: pre-filled pen with PT-141 (bremelanotide, melanocortin receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
Tirzepatide Pen 10 mg: pre-filled pen with tirzepatide (dual GIP/GLP-1 receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
